Exact Mass: 597.3513

Exact Mass Matches: 597.3513

Found 18 metabolites which its exact mass value is equals to given mass value 597.3513, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

5-O-beta-D-Mycaminosyltylonolide

5-O-β-D-Mycaminosyltylonolide

C31H51NO10 (597.3513)

Mycaminosyltylonolide

5-O-beta-D-Mycaminosyltylonolide

C31H51NO10 (597.3513)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007933 - Leucomycins Mycaminosyltylonolide is a potent antibiotic. Mycaminosyltylonolide shows antibacterial activity. Mycaminosyltylonolide inhibits luciferase synthesis[1][2].

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoic acid

(2E,4E,9R)-9-hydroxy-10-[(2R,4R,6S)-6-[(S)-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-methoxymethyl]-4-methoxy-3,3-dimethyloxan-2-yl]deca-2,4-dienoic acid

C31H51NO10 (597.3513)

5-O-mycaminosyltylonolide

C31H51NO10 (597.3513)

A macrolide antibiotic that is tylonolide having a beta-D-mycaminosyl residue attached at position 5.

DGCC 21:4;O2

C31H51NO10 (597.3513)

ST 23:1;O5;HexNAc

C31H51NO10 (597.3513)

(9-{[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl)acetic acid

C31H51NO10 (597.3513)

(2e,4e)-10-[(2r,4r,6s)-6-[(s)-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e)-10-[(2r,4r,6s)-6-[(s)-{[(2s)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

2-[(14e)-9-{[4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetaldehyde

C31H51NO10 (597.3513)

(2e,4e,9s)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e,9s)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

10-[6-({[1,2-dihydroxy-2-(2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl)ethylidene]amino}(methoxy)methyl)-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)

[(1s,2r,3r,7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3s,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetic acid

[(1s,2r,3r,7r,8s,9s,10r,12r,14e,16s)-9-{[(2s,3s,4s,6s)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]acetic acid

C31H51NO10 (597.3513)

(2e,4e,9r)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

(2e,4e,9r)-10-[(2r,4r,6s)-6-[(s)-{[(2r)-1,2-dihydroxy-2-[(2r,5r,6r)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]ethylidene]amino}(methoxy)methyl]-4-methoxy-3,3-dimethyloxan-2-yl]-9-hydroxydeca-2,4-dienoic acid

C31H51NO10 (597.3513)